UPDATE 2-Gilead results beat Street estimates as demand grows for HIV drug
July 30, 2019 at 17:35 PM EDT
Gilead Sciences Inc beat Wall Street estimates for second-quarter revenue and profit on Tuesday, driven by higher sales of HIV treatments, and the U.S. drugmaker raised its full-year sales forecast.
